Back to search
Vasculitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Vasculitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Vasculitis trials you may qualify forGiant cell arteritis (GCA) is an inflammation of the blood vessels. A dangerous complication is sudden vision loss due to insufficient blood supply to the optic…
Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in…
The goal of this open-label clinical trial is to evaluate the efficacy of AzaFol-PET/CT in the diagnosis of GCA (giant cell arteritis), to compare AzaFol- with…
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.
This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary…
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for pati…
Peripheral intravenous catheters (PIVCs) are widely used for vascular access and represent one of the most common invasive procedures in hospitalized patients.…
The purpose of the study is to determine wether a rituximab-based treatment compared to standard therapy (glucocorticoid alone) in patients with microscopic pol…